If others follow in the same path this stands to set some new priorities on how studies are conducted and the development of personalized medicine. BD
In a move likely to up the ante in the emerging Open Source Drug Discovery movement, GlaxoSmithKline have announced the donation of genomic profiling data for over 300 cancer cell lines to the National Cancer Institute's cancer Bioinformatics Grid (caBIG). According to NCI's FAQ, caBIG is "an open-source, open-access information network enabling cancer researchers to share tools, data, applications, and technologies according to agreed-upon standards and identified needs." caBIG is comprised of publicly-available datasets and open source software tools designed to interact with them.
GlaxoSmithKline Donates Cancer Genomics Dataset to Public Information Network
0 comments :
Post a Comment